-
Notifications
You must be signed in to change notification settings - Fork 271
New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
Call for Methylation Section #942
Comments
We'd love to see your contributions. From what you say, the addition of such a subsection seems apropos. For the sake of efficiency and this project's focus on open/collaborative writing, I recommend that you submit a public pull requests before you get too far along. This will help publicly document all your contributions, ensure that your additions pass automated checks, and make it easier for others to make comments on your proposed additions (and thereby ensure that you're on the right track in terms of content, formatting, etc). Authorship isn't decided immediately, since authors are defined as anyone who has met ICMJE authorship standards (defined here) at the time of submission. The "at the time of submission" part is critical, e.g. some contributors to the first release were not listed as authors because they did not indicate their approval of the final manuscript. @cgreene may have more to say about this. |
@evancofer's summary seems on point. Things that we required were participation. This means that if you submit a fully formed PR but it only comes from one account, that provides contribution credit to that person but not the others - who may have contributed behind the scenes but did not in a public, attributable way. To be an author requires meeting all of the criteria, and this does require approval of the manuscript to be submitted. We attempted to obtain this from everyone, but there were authors who did not respond despite efforts to reach out to them, so we included them in only the acknowledgements. |
Great, thanks for the quick response. We have already begun drafting content, it appears that the "time of submission" will be June 2019 correct? Thanks |
Yes, June 2019 is correct. |
Thanks for your quick responses. Brock, Alexander and I will discuss our next steps as we continue to draft the methylation section. |
Great. I'm excited to see what you all have been working on. It sounds like it would make a great addition! |
Thanks @evancofer and @cgreene. @jlevy44, @Christensen-Lab and I will circle up about how best to divide and contribute. |
Any updates on this? |
Hey there. No updates yet. I'll touch base with @AlexanderTitus and @Christensen-Lab so we can start to make more progress. |
I believe we're shooting to have something preliminary by mid-February to early-March. |
Just providing another update. We’ll be releasing our section through three separate PRs. I’ll PR some motivational material for why deep learning and methylation, and then @Christensen-Lab and @AlexanderTitus will review and edit text that I wrote surrounding methylation inference, predictions, and latent space, and each will submit a PR for their relevant methylation subsection. Hoping to release the intro soon to have something down and in the process of merging. |
Hey everyone, just giving an update. We're just waiting on internal edits before we send the entire section out (may update with a few new papers). Do you have a deadline of when you'd like for us to have this section in by? |
I don't know if there is a deadline for this section per se. The sooner you can get the internal edits in a PR, the sooner you can get some feedback on it. Based on the last PR, feedback may be a little slow, so it is better to post things sooner than later. |
Internal review is progressing, should have that PR soon... |
What's the best way to multiple PR one section? Internal reviews are complete. Just adding citations. We'd like to make 2-3 PRs, one for each author. |
I am not sure I understand the question, could you clarify? Either way, I am glad to know it's getting closer to PR stage. |
@evancofer the question is how to coordinate multiple related PRs so that each contributor gets credit for their text and there aren't complex merge conflicts. @jlevy44 as long as the PRs don't edit the same existing text, it should be okay to submit them all at once as separate PRs. The last one submitted can reference the PR numbers of the others to help coordinate review. Does that sound okay @evancofer? Note that the last methylation section PR struggled to find a qualified reviewer, so that may be a problem here as well. We haven't done it before, but maybe you could recruit an external reviewer (i.e. not an existing author) and we could acknowledge them? |
Our team has begun the PR process. You should expect 2 more PRs this week. Here are the order of the PR sections that our group will be submitting:
|
I agree with @agitter that finding qualified reviewers is the real issue here. If they have the time, either @michaelmhoffman or @lanagarmire are probably good choices, who IIRC were involved with the first iteration of the deep review |
Great. Is there anything I can do to help move things forward at this stage? |
Thanks for thinking of me, but given my commitments I need to prioritize contributions that will lead to a new paper. |
Happy to help and move the manuscript to move forward as a co-author.
Lana Garmire, PhD
Associate Professor (with tenure)
Department of Computational Medicine and Bioinformatics
School of Medicine
University of Michigan
groupwebsite: garmiregroup.org
…On Sat, May 11, 2019 at 8:09 AM Michael Hoffman ***@***.***> wrote:
Thanks for thinking of me, but given my commitments I need to prioritize
contributions that will lead to a new paper.
—
You are receiving this because you were mentioned.
Reply to this email directly, view it on GitHub
<#942 (comment)>,
or mute the thread
<https://github.com/notifications/unsubscribe-auth/ACFEMOY67C5NZ6ZM2FP3DFDPU2ZRFANCNFSM4GIDQ5BQ>
.
|
@jlevy44 I think our efforts right now should focus on continuing to update existing sections, and summarizing and discussing new work using the GitHub issues. @michaelmhoffman No problem. Thank you for filling us in on the situation! @lanagarmire We'd love to have your contribution. If you're up to reviewing some of the methylation content, I think there are three PRs open right now that cover the methylation sections:
@cgreene Is there a previous PR that stands out as the "ideal" example of how we should do these PR-based reviews? I think it might be useful for onboarding reviewers, and could be worth mentioning in |
@evancofer : this was a new subsection, and may be a good example to work from: |
@lanagarmire We'll be more than happy to have you review our sections. |
Thank you for the help! |
If there is anything we can do to facilitate review, please let us know. We would love to have this section included in the next iteration of the review released, as it adds to the completeness of the review. |
@evancofer @cgreene What would you recommend as the next steps for the completion of this review? In particular, what might be some action steps for @lanagarmire to review our content? Thanks! |
I will have a block of time early next week. Is the draft ready for QC/check? |
@lanagarmire I think their current draft is ready for QC. @jlevy44 any last minute changes? |
@lanagarmire @evancofer I think we're all good to go. Thanks! |
Do you know why Travis failed? Might be good to clean that up first too.
Can't merge until it passes, even if PR approved.
…On Wed, Jun 12, 2019, 1:30 PM Joshua Levy ***@***.***> wrote:
@lanagarmire <https://github.com/lanagarmire> @evancofer
<https://github.com/evancofer> I think we're all good to go.
One of our PRs did not pass through Travis, but should be okay
content-wise.
Thanks!
—
You are receiving this because you were mentioned.
Reply to this email directly, view it on GitHub
<#942?email_source=notifications&email_token=AAEEPM3CD435GIZYETGUZNTP2DM55A5CNFSM4GIDQ5B2YY3PNVWWK3TUL52HS4DFVREXG43VMVBW63LNMVXHJKTDN5WW2ZLOORPWSZGODXQDLLY#issuecomment-501233071>,
or mute the thread
<https://github.com/notifications/unsubscribe-auth/AAEEPM4A3KOADVGEGSR73WDP2DM55ANCNFSM4GIDQ5BQ>
.
|
@cgreene it looks like a space vs. tab failure in the tags file #956 (comment) |
I thought that there was a mechanism in place to automatically reread the tsv with a new delimiter. If you check the Travis output for my PR, the same error may be embedded? |
@lanagarmire looking forward to your review of our material. Hopefully we can finish this review before the submission of the manuscript. Please let me know what I can do to help move things forward. |
Does this qualify me as a co-author? Forgot to ask...need to prioritize my
time wisely, obviously. Thanks.
…On Thu, Jun 20, 2019, 8:02 PM Joshua Levy ***@***.***> wrote:
@lanagarmire <https://github.com/lanagarmire> looking forward to your
review of our material. Hopefully we can finish this review before the
submission of the manuscript. Please let me know what I can do to help move
things forward.
—
You are receiving this because you were mentioned.
Reply to this email directly, view it on GitHub
<#942?email_source=notifications&email_token=ACFEMO5RUSPHRNQT3EXIO3LP3QLBVA5CNFSM4GIDQ5B2YY3PNVWWK3TUL52HS4DFVREXG43VMVBW63LNMVXHJKTDN5WW2ZLOORPWSZGODYHBVFI#issuecomment-504240789>,
or mute the thread
<https://github.com/notifications/unsubscribe-auth/ACFEMO75X4TWPOLY742EMC3P3QLBVANCNFSM4GIDQ5BQ>
.
|
@lanagarmire It will depend on the extent to which your review meets the ICMJE guidelines: The two that are most in question here (the others are approval/agreement) are:
If you make specific suggestions to the text that revise it for critically important content (now far more trackable via github's suggest changes feature, which I would strongly encourage you to use so that your suggestions can be tracked) that get incorporated, and make contributions to the design of the sections (i.e., if you identify substantial changes that improve clarity or identify missing areas/literature that should be covered), that would qualify. On the other hand, if the changes are primarily copyediting, etc then that wouldn't qualify. If you are uncomfortable with this, then I wouldn't encourage you to do it and we can find another path. If this is something you are comfortable with, we would like to benefit from your expertise! |
@jlevy44 : Can someone accept @agitter's change on #956 The permissions on the fork are set such that I don't have permission to commit to @brockclarke's branch there. |
I already contrbuted to critical suggestions before the writing. That is
why I was asked to QC.
But if you don't think that matter then i will pass this one.
…On Fri, Jun 21, 2019, 8:07 AM Casey Greene ***@***.***> wrote:
@lanagarmire <https://github.com/lanagarmire> It will depend on the
extent to which your review meets the ICMJE guidelines:
https://github.com/greenelab/deep-review/blob/master/CONTRIBUTING.md#authorship
The two that are most in question here (the others are approval/agreement)
are:
Substantial contributions to the conception or design of the work; or the
acquisition, analysis, or interpretation of data for the work; AND
Drafting the work or revising it critically for important intellectual
content; AND
If you make specific suggestions to the text that revise it for critically
important content (now far more trackable via github's suggest changes
feature, which I would strongly encourage you to use so that your
suggestions can be tracked) that get incorporated, and make contributions
to the design of the sections (i.e., if you identify substantial changes
that improve clarity or identify missing areas/literature that should be
covered), that would qualify.
On the other hand, if the changes are primarily copyediting, etc then that
wouldn't qualify.
If you are uncomfortable with this, then I wouldn't encourage you to do it
and we can find another path. If this is something you are comfortable
with, we would like to benefit from your expertise!
—
You are receiving this because you were mentioned.
Reply to this email directly, view it on GitHub
<#942?email_source=notifications&email_token=ACFEMO3NTPEVVVNM3MNW6B3P3TABJA5CNFSM4GIDQ5B2YY3PNVWWK3TUL52HS4DFVREXG43VMVBW63LNMVXHJKTDN5WW2ZLOORPWSZGODYIJC7Y#issuecomment-504402303>,
or mute the thread
<https://github.com/notifications/unsubscribe-auth/ACFEMO5BHVGY6JPJ6BF7HLLP3TABJANCNFSM4GIDQ5BQ>
.
|
@lanagarmire : Each contribution matters, but I don't think there would be anyone who could guarantee that ICMJE guidelines for authorship would be met before the review is done. If you feel you need to pass, I totally understand. |
Good luck to your review!!!
…On Fri, Jun 21, 2019, 10:01 AM Casey Greene ***@***.***> wrote:
@lanagarmire <https://github.com/lanagarmire> : Each contribution
matters, but I don't think there would be anyone who could guarantee that
ICMJE guidelines for authorship would be met before the review is done. If
you feel you need to pass, I totally understand.
—
You are receiving this because you were mentioned.
Reply to this email directly, view it on GitHub
<#942?email_source=notifications&email_token=ACFEMO7X4CCSHYCENEPRLFLP3TNKBA5CNFSM4GIDQ5B2YY3PNVWWK3TUL52HS4DFVREXG43VMVBW63LNMVXHJKTDN5WW2ZLOORPWSZGODYIRP5Y#issuecomment-504436727>,
or mute the thread
<https://github.com/notifications/unsubscribe-auth/ACFEMO5W7RXTEECOWBQXB3DP3TNKBANCNFSM4GIDQ5BQ>
.
|
@brockclarke Can you accept @agitter ‘s change on #956 ? @lanagamire Thanks! @cgreene @agitter @evancofer |
Hey @cgreene , can you provide us an update with the status of the review of these 3 PRs? Thanks! Looking forward to moving our contributions to their final state. If we could also add this manuscript to the review before submission that would be great: https://www.biorxiv.org/content/10.1101/692665v1 |
Getting this moving again is one of my three main goals of this week! 🤞 |
Wonderful. Thanks @cgreene ! |
Please take me off this thread.thx
…On Wed, Jul 17, 2019, 7:33 AM Joshua Levy ***@***.***> wrote:
Wonderful. Thanks @cgreene <https://github.com/cgreene> !
—
You are receiving this because you were mentioned.
Reply to this email directly, view it on GitHub
<#942?email_source=notifications&email_token=ACFEMO3ALAWJQCMK4VLJHLDP737QJA5CNFSM4GIDQ5B2YY3PNVWWK3TUL52HS4DFVREXG43VMVBW63LNMVXHJKTDN5WW2ZLOORPWSZGOD2D4WXQ#issuecomment-512215902>,
or mute the thread
<https://github.com/notifications/unsubscribe-auth/ACFEMO2BVVDX43V4ZJQ7E4LP737QJANCNFSM4GIDQ5BQ>
.
|
@lanagarmire : your github preferences have you subscribed - nobody else can remove you, but these instructions might be helpful: |
I think we can wrap this up and close this issue once #959 is resolved. Thanks! |
Any interest in having us update this section? |
This methylation section is one of the most recently written parts of the review, so I don't see a major need to update it. That said, the initial version was added over a year ago, so we would welcome updates if you have them. It may take us a while to review any updates. |
Is there a plan to publish an updated version of this review?
There are of course publications in the past year that we could include, but we would not want to delay publication plans, or go to the work if there aren’t plans in place
|
There are still vague plans to publish an update at some point. However, given the current activity level of contributors who are helping write content and review pull requests, I don't think we can set a timeline for the next submission. |
I’ve been reading through the deep review paper and noticed that there is not a Methylation section in this paper. There are a number of issues that have been brought up regarding the inclusion of methylation deep learning papers (#68 #39 #244 #923 #922 #910 #692 ). The only paper I see explicitly mentioned in the paper for deep learning exclusively for methylation data types is DeepCpG (I’ve read the referenced multimodal approaches). However, it seems like there are quite a few papers that demonstrate significant strides in Deep Learning and methylation, most of which are enumerated below:
- http://www.scitepress.org/DigitalLibrary/Link.aspx?doi=10.5220/0006636401400145
- https://www.biorxiv.org/content/early/2018/11/07/433763
I believe that the inclusion of methylation in the deep learning paper has been limited, and propose that we include a Methylation section of the paper under the “Deep learning to study the fundamental biological processes underlying human disease section”.
Brock Christensen @Christensen-Lab, Alexander Titus @AlexanderTitus, and I have been working together to draft a Methylation section for the deep review paper, which we are revising internally, and would be happy to submit a pull request soon. The three of us would also like to be included as authors in the paper.
The text was updated successfully, but these errors were encountered: